Novo Holdings A/S
Danish holding company / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Novo Holdings A/S?
Summarize this article for a 10 year old
Novo Holdings A/S (formerly Novo A/S)[1] is the Novo Nordisk Foundation's wholly owned holding company for Novo Nordisk A/S and Novozymes A/S. Novo Holdings A/S was established in 1999 and manages the Novo Nordisk Foundation's assets, which in 2023 was worth almost DKK 1,114 billion.[2][3][4] Danish Kroner (approximately US$163 billion) and is the largest charitable foundation in the world making Novo Holdings A/S a world-leading life sciences investor.[5] Novo Holdings A/S is headquartered in Copenhagen, Denmark, with offices in San Francisco, Boston and Singapore.
Company type | Private limited company |
---|---|
Industry | Life Sciences Asset management |
Founded | 1999 |
Headquarters | , |
Key people | Kasim Kutay(CEO) Lars Rebien Sørensen(Chairman) |
Services | Investments in Life Science |
Total assets | DKK 1,114 billion (2023) Approx. $163 billion (2023) |
Subsidiaries | Novo Nordisk A/S Novozymes A/S |
Website | www |
Eivind Kolding succeeded Henrik Gürtler as CEO on 1 May 2014.[6] Eivind Kolding left Novo Holdings A/S in March 2016 and Kasim Kutay took over as CEO for the organisation.[7]